Morowski Martina, Brachs Sebastian, Mielenz Dirk, Nieswandt Bernhard, Dütting Sebastian
University of Würzburg, Department of Experimental Biomedicine, University Hospital and Rudolf Virchow Center for Experimental Biomedicine, Würzburg, Germany.
Division of Molecular Immunology, Department of Internal Medicine III, Nikolaus Fiebiger Center, University Hospital Erlangen and University of Erlangen-Nürnberg, Erlangen, Germany.
PLoS One. 2014 Sep 22;9(9):e107139. doi: 10.1371/journal.pone.0107139. eCollection 2014.
Platelets are anuclear cell fragments derived from bone marrow megakaryocytes that safeguard vascular integrity, but may also cause pathological vessel occlusion. Reorganizations of the platelet cytoskeleton and agonist-induced intracellular Ca2+-mobilization are crucial for platelet hemostatic function. EF-hand domain containing 2 (EFhd2, Swiprosin-1) is a Ca2+-binding cytoskeletal adaptor protein involved in actin remodeling in different cell types, but its function in platelets is unknown.
Based on the described functions of EFhd2 in immune cells, we tested the hypothesis that EFhd2 is a crucial adaptor protein for platelet function acting as a regulator of Ca2+-mobilization and cytoskeletal rearrangements.
We generated EFhd2-deficient mice and analyzed their platelets in vitro and in vivo. Efhd2-/- mice displayed normal platelet count and size, exhibited an unaltered in vivo life span and showed normal Ca2+-mobilization and activation/aggregation responses to classic agonists. Interestingly, upon stimulation of the immunoreceptor tyrosine-based activation motif-coupled receptor glycoprotein (GP) VI, Efhd2-/- platelets showed a slightly increased coagulant activity. Furthermore, absence of EFhd2 had no significant impact on integrin-mediated clot retraction, actomyosin rearrangements and spreading of activated platelets on fibrinogen. In vivo EFhd2-deficiency resulted in unaltered hemostatic function and unaffected arterial thrombus formation.
These results show that EFhd2 is not essential for platelet function in mice indicating that other cytoskeletal adaptors may functionally compensate its loss.
血小板是源自骨髓巨核细胞的无核细胞碎片,可维护血管完整性,但也可能导致病理性血管阻塞。血小板细胞骨架的重组以及激动剂诱导的细胞内钙离子动员对于血小板的止血功能至关重要。含EF手结构域2(EFhd2,Swiprosin-1)是一种钙离子结合细胞骨架衔接蛋白,参与不同细胞类型的肌动蛋白重塑,但其在血小板中的功能尚不清楚。
基于EFhd2在免疫细胞中的所述功能,我们检验了以下假设,即EFhd2是血小板功能的关键衔接蛋白,作为钙离子动员和细胞骨架重排的调节剂。
我们构建了EFhd2基因敲除小鼠,并在体外和体内分析了它们的血小板。Efhd2基因敲除小鼠的血小板计数和大小正常,体内寿命未改变,对经典激动剂的钙离子动员以及激活/聚集反应正常。有趣的是,在刺激基于免疫受体酪氨酸激活基序的偶联受体糖蛋白(GP)VI后,Efhd2基因敲除小鼠的血小板显示出凝血活性略有增加。此外,缺乏EFhd2对整合素介导的血块回缩、肌动球蛋白重排以及活化血小板在纤维蛋白原上的铺展没有显著影响。在体内,EFhd2缺乏导致止血功能未改变且动脉血栓形成未受影响。
这些结果表明,EFhd2对小鼠的血小板功能并非必不可少,这表明其他细胞骨架衔接蛋白可能在功能上补偿其缺失。